BRUSSELS: A vaccine scheme co-led by the World Health Organization is setting up a compensation fund for people in poor nations who might suffer any side-effects from COVID-19 vaccines, aiming to allay fears that could hamper a global rollout of shots and prolong the pandemic.
The scheme is being set up by the promoters of the COVAX vaccine facility, which is co-led by the WHO and GAVI, a vaccine alliance.
WHAT IS COVAX?
COVAX is one of three pillars of the Access to COVID-19 Tools (ACT) Accelerator, which was launched in April by the World Health Organization (WHO), the European Commission and France in response to this pandemic.
Bringing together governments, global health organisations, manufacturers, scientists, private sector, civil society and philanthropy, with the aim of providing innovative and equitable access to COVID-19 diagnostics, treatments and vaccines.
The COVAX pillar is focussed on the latter. It is an effort to ensure that people in all corners of the world will get access to COVID-19 vaccines once they are available, regardless of their wealth.